ArticleEClinicalMedicine2022

Kidney outcomes associated with sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists: A real-world population-based analysis.

David Tak Wai Lui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.